AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Tacrogem 0.03% Ointment

Prescription Icon
Prescription Required

Marketer

Agron Remedies Pvt Ltd

Salt Composition

Tacrolimus (0.03% w/w)

Overview Tacrogem 0.03% Ointment

Eczema (atopic dermatitis) is treated with Tacrogem 0.03% Ointment, which reduces inflammation (skin redness and swelling) by modulating the activity of specific immune cells. This soothes itching and improves atopic dermatitis rashes. Apply Tacrogem 0.03% Ointment topically, 2-4 times daily to affected areas, or as directed by your physician. Gently and evenly rub the ointment into the skin. Avoid overuse and do not cover treated areas with bandages. Report any lack of improvement after two weeks or worsening skin condition. Potential side effects include redness (erythema), headache, folliculitis, and application site reactions such as burning, irritation, itching, and redness. Use during pregnancy or breastfeeding is generally discouraged unless deemed essential by a healthcare professional.

Uses of Tacrogem 0.03% Ointment

Managing atopic dermatitis

Major Benefits of Tacrogem 0.03% Ointment:

Apply this medication only to the skin's surface. Follow your physician's instructions precisely regarding dosage and treatment length. Always consult the product label for application details prior to use. Ensure the affected area is clean and dry before gently rubbing in the ointment.

Common Side effects of Tacrogem 0.03% Ointment:

  • Application site reactions (burning, irritation, itching and redness)
  • Headache
  • Hair follicle inflammation

How to use Tacrogem 0.03% Ointment:

Apply this medication topically only. Follow your physician's prescribed dosage and treatment schedule. Always refer to the product label for application instructions. Ensure the affected skin is clean and dry before applying the ointment with a gentle rubbing motion.

How Tacrogem 0.03% Ointment works:

Tacrolimus 0.03% ointment, an immunosuppressant medication, reduces skin inflammation by inhibiting the action of specific immune cells. This action alleviates itching and improves the appearance of rashes associated with atopic dermatitis.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Tacrogem 0.03% Ointment during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before use.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Applying Tacrogem 0.03% ointment while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingNone

No drug interaction identified.

KidneyKidneyNone

No known drug interactions.

LiverLiverNone

No known drug interactions.

What if you forget to take Tacrogem 0.03% Ointment :

For Tacrogem 0.03% Ointment, apply a forgotten dose promptly. If your next application is imminent, omit the missed dose and resume your usual dosing regimen.

Facts to Know About Tacrogem 0.03% Ointment

LabelValue
Type of Compound Large-ring lactone antibiotics
Potential for Dependence None.
Medication Classification Cancer therapeutics
Mechanism of Action Drugs that suppress the immune system: Calcineurin inhibitor class.

FAQs on Tacrogem 0.03% Ointment

Tacrolimus 0.03% ointment is an immunomodulatory medication that primarily suppresses immune system activity. It's indicated for treating moderate to severe atopic dermatitis in adults who haven't responded to, or experience adverse effects from, steroid treatments. Atopic dermatitis involves an overactive skin immune response, resulting in inflammation, itching, redness, and dryness. This ointment targets this aberrant immune response, modifying it to alleviate skin inflammation and itching.
Topical application of Tacrogem 0.03% Ointment can induce localized skin reactions. These may include mild to moderate burning, itching, and irritation, typically subsiding within seven days of treatment initiation. Redness, warmth, pain, altered sensation, and rash are also frequently observed at the application site. Treatment is associated with a heightened risk of folliculitis, herpes simplex outbreaks, acne, and generalized herpes simplex infections.
Tacrogem 0.03% Ointment offers a safe and effective short-term topical treatment for atopic dermatitis, exhibiting superior safety compared to other immunosuppressant medications. Its minimal systemic absorption following cutaneous application results in fewer adverse effects than oral immunosuppressants.
Tacrolimus 0.03% ointment is not a controlled substance and poses no risk of misuse. Controlled substances, by definition, have a potential for abuse, requiring authorization from both medical professionals and regulatory bodies.
Prolonged application of Tacrogem 0.03% Ointment is associated with a heightened lymphoma risk, a type of lymph node tumor. Limited research indicates a link between Tacrogem 0.03% Ointment, or comparable drugs, and the development of skin cancer or lymphoma in a small number of users. Seek medical advice if Tacrogem 0.03% Ointment use exceeds six weeks, or if your eczema symptoms fail to improve or worsen despite treatment.
Tacrogem 0.03% Ointment is non-steroidal. This medication modifies immune system function and treats eczema, particularly atopic dermatitis. Unlike steroids, Tacrogem 0.03% Ointment does not thin the skin or produce other steroid-associated adverse reactions.
Tacrogem 0.03% Ointment
213
MRP 260
18% off